Elsevier, Diet and Nutrition in Neurological Disorders, Volume , 1 January 2023
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced inequalities by exploring the disability-adjusted life years (DALYs) caused by neurological disorders and the effect of that burden on society.
Elsevier, Computational Methods and Deep Learning for Ophthalmology, Volume , 1 January 2023
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by systematically appraising the common applications of deep learning approaches and the utilization of big public health data to detect the risks of blindness within communities.
Elsevier, Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging, Volume , 1 January 2023
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by showing CBT as a helpful treatment for many youths with autism and anxiety, with the modular format of an adapted CBT approach showing additional advantages in reducing interfering and maladaptive anxiety.
Elsevier, Current Topics in Developmental Biology, Volume 152, January 2023
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by providing evidence that environmental factors influence individual risk and/or severity of autism spectrum disorders.
Elsevier, Advances in Child Development and Behavior, Volume 64, January 2023
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by presenting ASD as a complex, multisystem neurodevelopmental condition with origins in prenatal life.
Elsevier, Advances in Epidemiological Modeling and Control of Viruses 2023, Pages 29-54
This content supports the SDG Goal 3: Good health and well-being by formulating an epidemiological mathematical model that demonstrates the transmission of the hepatitis B virus for use in research.
Elsevier, Overcoming Obstacles in Drug Discovery and Development
Surmounting the Insurmountable—Case Studies for Critical Thinking
2023, Pages 215-222
This content aligns with Goal 3: Good Health and Wellbeing by identifying the reactive metabolite responsible for the species-specific nephrotoxicity observed in rats dosed with efavirenz provide a framework for addressing nonclinical toxicities and clinical risk and providing a solid scientific basis for regulatory review.